Financials data is unavailable for this security.
View more
Year on year Accelerate Diagnostics Inc has grown net income from a loss of -62.49m to a smaller loss of -61.62m despite declining revenues.
Gross margin | 27.16% |
---|---|
Net profit margin | -309.87% |
Operating margin | -354.35% |
Return on assets | -104.22% |
---|---|
Return on equity | -- |
Return on investment | -1,349.93% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Accelerate Diagnostics Inc fell by 22.77m. Cash Flow from Financing totalled 9.02m or 74.79% of revenues. In addition the company used 40.20m for operations while cash from investing totalled 8.66m.
Cash flow per share | -1.93 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -1.47 |
---|---|
Tangible book value per share | -1.47 |
More ▼
Balance sheet in USDView more
Current ratio | 1.28 |
---|---|
Quick ratio | 1.04 |
Total debt/total equity | -- |
---|---|
Total debt/total capital | 6.38 |
More ▼